Skip to main content

Rakesh Jhunjhunwala buys 50 lakh shares of this firm, stock gains 5%

The small cap share gained up to 4.85% to Rs 187.90 against previous close of Rs 179.20 on BSE

 

Share price of Dishman Carbogen Amcis was trading higher in early trade after ace investor Rakesh Jhunjhunwala and his wife Rekha Jhunjhunwala bought 3.18% stake in the firm in June quarter.  Jhunjhunwala  and his wife bought 25 lakh shares each in the company.

 Dishman Carbogen Amcis  share gained up to 4.85% to Rs 187.90 against previous close of Rs 179.20 on BSE. The stock opened with a gain of 2.3% at Rs 183.40 today. The share has lost 14.14% in one year and gained 111.95% since the beginning of this year. 

 In a month, the small cap share has risen 47%. Total 0.55 lakh shares changed hands amounting to turnover of Rs 1.03 crore. Market cap of the firm rose to Rs 2,915 crore. The share hit 52 week high of Rs 218.30 on September 29, 2019 and 52-week low of Rs 46.45 on March 30, 2020.


 The firm is engaged in the process of research and development to late-stage clinical and commercial manufacturing. It operates through nine manufacturing sites in Europe, India, China and Saudi Arabia.

 Apart from Dishman Carbogen, the big bull raised stake and bought shares in other firms in Q1 of the current fiscal. He raised stake in pharma firm Jubilant Life Sciences in Q1. Jhunjhunwala held 81,45,800 shares in the firm in last quarter against 70,25,000 shares held in the March quarter. In three separate accounts, Jhunjhunwala had 31,25,800 shares, 25,20,000 shares and 25,00,000 shares in Q1.

 In March quarter, the ace investor held 43,72,222 and 26,52,778 shares of the company in two different accounts.

The ace investor bought 1.05 per cent stake or 1.25 crore shares of Indian Hotels in Q1. He was not among the key shareholders of the company earlier, data available with Ace Equity show.

In Rallis India, Jhujhunwala raised his stake by 0.38 per cent during June quarter.

 Jhunjhunwala purchased an additional 7.25 lakh equity shares to raise his stake to 10.31 per cent during the April-June period. He holds shares in the Tata Group company through his two accounts-Rakesh Radheshyam Jhunjhunwala (7.64 per cent) and Rakesh Jhunjhunwala (2.67 per cent), shareholding pattern on BSE showed.

 Jhunjhunwala held 1,93,05,820 shares (or 9.93 per cent stake) in the agrochemicals firm at the end of March 2020 against 1,90,30,820 shares at the end of December 2019.

 In Federal Bank too, Jhunhjunwala bought an additional 20 lakh shares in the quarter ended June 2020. In June quarter, Jhunhjunwala's total holding in the bank stood at 3.18 percent in the quarter ended June 2020 against 3.08 percent in March 2020.In last quarter, the big bull held 6.23 crore shares against 6.03 crore shares held by him for quarter ended March.


Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...